Frohn Mike, Xu Han, Zou Xiaoming, Chang Catherine, McElvaine Michele, Plant Matthew H, Wong Min, Tagari Philip, Hungate Randall, Bürli Roland W
Chemistry Research and Discovery, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
Bioorg Med Chem Lett. 2007 Dec 1;17(23):6633-7. doi: 10.1016/j.bmcl.2007.09.043. Epub 2007 Sep 15.
We report the development of the novel N-substituted benzimidazole 11 as a potent and selective human formyl peptide receptor-like 1 (hFPRL1) agonist. This compound and its less active enantiomer 12 were identified as useful tools for studying receptor function in vitro.
我们报道了新型N-取代苯并咪唑11作为一种强效且选择性的人甲酰肽受体样1(hFPRL1)激动剂的研发情况。该化合物及其活性较低的对映体12被确定为用于体外研究受体功能的有用工具。